News
Swiss drugmaker, Novartis, reports flat net profit for the third quarter of 2012 in the same week it defends the safety of its flu vaccines in Italy. Novartis has reported a net profit of $2.48 billion in the third quarter, which was more or less the same as…
Sanofi’s Q3 profit drops 23%, which is less than estimated by analysts. Sanofi reported a 23 percent decline in profits for Q3. It also expects that full-year profit will fall from last year, however, full-year earnings…
Bristol-Myers Squibb reported a third quarter financial decrease in net sales, compared with the same period a year ago. Bristol-Myers Squibb today reported it s third quarter financial results. It announced net sales of $3.7 billion, a decrease of 30% compared with…
Patent expirations attributed to a fall in revenue from big pharma, Eli Lilly & Co, announced today in the company’s third quarter report. Eli Lilly & Co has announced its third quarter results, with worldwide total revenue down 11% compared to…
A 10% increase in profits has been announced by Amgen for the third quarter of 2012. Third-quarter financial results for Amgen have been announced. Under its first full quarter with Robert Bradway as…
Following its European approval back in September, Eisai’s epilepsy drug Fycompa has now been approved for use in the United States. The US Food and Drug Administration (FDA) has approved Japanese drugmaker Eisai’s antiepileptic drug…
Pfizer is to acquire NextWave Pharma, the makers of the first liquid medication for ADHD to be approved in the US. Pfizer is to acquire NextWave Pharmaceuticals, which specializes in the development and commercialization of unique products…
Dr Reddy’s Laboratories has made an offer to acquire OctoPlus so it can expand its research in the Netherlands. India-based pharmaceutical company, Dr Reddy’s Laboratories, has announced an intended public offer to acquire the…
Novo Nordisk’s long-acting insulin, Tresiba, receives a recommendation for approval in Europe by the EMA. The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended that Novo Nordisk’s long-acting…
